Abstract

The development of novel theranostic nanovectors is of particular interest in treating formidable diseases (e.g., cancers). Herein, we report a new tumor-targetable theranostic agent based on core crosslinked (CCL) micelles, possessing tumor targetable moieties and fluorescence and magnetic resonance (MR) dual imaging modalities. An azide-terminated diblock copolymer, N3-POEGMA-b-P(DPA-co-GMA), was synthesized via consecutive atom transfer radical polymerization (ATRP), where OEGMA, DPA, and GMA are oligo(ethylene glycol)methyl ether methacrylate, 2-(diisopropylamino)ethyl methacrylate, and glycidyl methacrylate, respectively. The resulting diblock copolymer was further functionalized with DOTA(Gd) (DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakisacetic acid) or benzaldehyde moieties via copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) chemistry, resulting in the formation of DOTA(Gd)-POEGMA-b-P(DPA-co-GMA) and benzaldehyde-POEGMA-b-P(DPA-co-GMA) copolymers. The resultant block copolymers co-assembled into mixed micelles at neutral pH in the presence of tetrakis[4-(2-mercaptoethoxy)phenyl]ethylene (TPE-4SH), which underwent spontaneous crosslinking reactions with GMA residues embedded within the micellar cores, simultaneously switching on TPE fluorescence due to the restriction of intramolecular rotation. Moreover, camptothecin (CPT) was encapsulated into the crosslinked cores at neutral pH, and tumor-targeting pH low insertion peptide (pHLIP, sequence: AEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTCG) moieties were attached to the coronas through the Schiff base chemistry, yielding a theranostic nanovector with fluorescence and MR dual imaging modalities and tumor-targeting capability. The nanovectors can be efficiently taken up by A549 cells, as monitored by TPE fluorescence. After internalization, intracellular acidic pH triggered the release of loaded CPT, killing cancer cells in a selective manner. On the other hand, the nanovectors labeled with DOTA(Gd) contrast agents exhibited increased relaxivity (r1 = 16.97 mM−1·s−1) compared to alkynyl-DOTA(Gd) small molecule precursor (r1 = 3.16 mM−1·s−1). Moreover, in vivo MRI (magnetic resonance imaging) measurements revealed CCL micelles with pHLIP peptides exhibiting better tumor accumulation and MR imaging performance as well.

Highlights

  • The combination integration of diagnostic and therapeutic functionalities into one system generates theranostic platforms, which is quite appealing because of the potential for developing personalized nanomedicine [1,2,3,4]

  • Block copolymers consisting of pendent epoxy residues within the pH-responsive blocks, POEGMA-b-P(DPA-co-Glycidylmethacrylate methacrylate (GMA)), was synthesized via atom transfer radical polymerization (ATRP) technique, followed by introduction of magnetic resonance (MR) imaging contrast agent and benzaldehyde moieties via CuAAC click chemistry

  • The as-prepared block copolymers self-assembled into micellar nanoparticles in aqueous solution at neutral pH, and crosslinking occurred within the micellar cores in the presence of TPE-4SH, which was simultaneously loaded into the hydrophobic cores of the micellar nanoparticles during the self-assembly process

Read more

Summary

Introduction

The combination integration of diagnostic and therapeutic functionalities into one system generates theranostic platforms, which is quite appealing because of the potential for developing personalized nanomedicine [1,2,3,4]. In this context, tremendous research has been carried out on the basis of inorganic nanoparticles [5], supramolecular assemblies [6,7], and hybrid materials [8,9], which are integrated with diverse imaging modalities and therapeutic agents. A number of strategies have been applied such as shell/core crosslinking (SCL/CCL) and unimolecular assemblies to maintain the assembly microstructures during blood circulation [28,29,30,31,32,33,34,35,36,37,38,39,40,41]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.